| Mar 12 2024 |
FDA Publishes Stance on Titanium Dioxide in Food |
Keller and Heckman LLP |
| Mar 11 2024 |
NIOSH Highlights 20 Years of Research on Engineering Controls for Nanotechnology |
Bergeson & Campbell, P.C. |
| Mar 11 2024 |
Delta-Nope: Florida Poised to Ban Delta-8 and Delta-10 Products |
Bradley Arant Boult Cummings LLP |
| Mar 11 2024 |
Competition Currents | March 2024 |
Greenberg Traurig, LLP |
| Mar 11 2024 |
Healthcare Preview for the Week of: March 11, 2024 [Podcast] |
McDermott Will & Schulte LLP |
| Mar 11 2024 |
USDA Releases Reports on Economic Impact Analysis of the U.S. Biobased Products Industry and on Hemp Research and Innovation |
Bergeson & Campbell, P.C. |
| Mar 11 2024 |
The Return of the New York Junk Food Bill |
Keller and Heckman LLP |
| Mar 9 2024 |
Oregon Prescription Drug Price Transparency Act in Limbo |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 8 2024 |
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US |
Keller and Heckman LLP |
| Mar 8 2024 |
BioMarin Subpoena Potentially Signals Continued Investigations into Sponsored Testing Programs |
Epstein Becker & Green, P.C. |
| Mar 8 2024 |
UK Spring Budget 2024 |
Cadwalader, Wickersham & Taft LLP |
| Mar 8 2024 |
Georgia Laboratory Owner Pleads Guilty to Felony Anti-Kickback Statute Violations |
ArentFox Schiff LLP |
| Mar 7 2024 |
Health Law Diagnosed – A Discussion on the Regulatory Requirements for LDTs [Podcast] |
Mintz |
| Mar 7 2024 |
Making Moves – FDA’s LDT Proposed Rule Sent to OMB for Review |
Epstein Becker & Green, P.C. |
| Mar 7 2024 |
China on the Move: Lessons from China’s 2023 National Negotiation of Drug Prices |
Greenberg Traurig, LLP |
| Mar 6 2024 |
ACA-Required Coverage of Contraceptive Care Remains Agency Focus |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 6 2024 |
Implementation of Strengthening Organic Enforcement Rule Begins this Month |
Keller and Heckman LLP |
| Mar 6 2024 |
FDA Faces Critical Deadlines in 2024, Even Without an Election Looming |
Mintz |
| Mar 6 2024 |
Medical Marijuana Usage Is Not Protected Under the ADA, Vermont Federal Court Rules |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 5 2024 |
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast [Podcast] |
K&L Gates LLP |
| Mar 5 2024 |
Cannabis Legalization Efforts: How Far Did They Reach in 2023? How High Can They Go in an Election Year? |
Womble Bond Dickinson (US) LLP |
| Mar 5 2024 |
DOE Intends to Issue Funding to Support Mixed Algae and Wet Waste Feedstocks R&D for Biofuels and Bioproducts |
Bergeson & Campbell, P.C. |
| Mar 5 2024 |
Unpacking Averages: Analyzing FDA’s Performance in Finalizing Guidance Documents |
Epstein Becker & Green, P.C. |
| Mar 5 2024 |
SAMHSA Final Rule Regarding OTPs Expands Access, Increases Flexibility for Patients |
Epstein Becker & Green, P.C. |
| Mar 5 2024 |
CA Federal Court Awards Biomedical Companies $62M Following Jury Trial Involving Confidentiality-Related Claims |
Proskauer Rose LLP |
| Mar 5 2024 |
FDA Updates List of Chemicals Under Review |
Keller and Heckman LLP |
| Mar 4 2024 |
FDA Issues Update on Post-Market Assessments of Chemicals in the Food Supply |
Bergeson & Campbell, P.C. |
| Mar 4 2024 |
From the Year of the Rabbit to the Year of the Dragon: China’s Food Law Year-in-Review 2023 |
Keller and Heckman LLP |
| Mar 4 2024 |
USDA Seeks Comments on Petition to Deregulate Corn Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
| Mar 4 2024 |
New York Attorney General Sues JBS for its Climate Claims |
Womble Bond Dickinson (US) LLP |
| Mar 4 2024 |
Navigating Hemp THC Beverages |
McDermott Will & Schulte LLP |
| Mar 4 2024 |
Alabama Supreme Court Rules Negligent Destruction of IVF Embryos May Be Treated as Wrongful Death |
Greenberg Traurig, LLP |
| Mar 1 2024 |
CODEX ALIMENTARIUS: Outcome of 7th Codex Committee – Spices and Culinary Herbs (CCSCH7) |
Keller and Heckman LLP |
| Mar 1 2024 |
European Industries Call for “Bold and Impactful” Biotechnology and Biomanufacturing Initiative |
Bergeson & Campbell, P.C. |
| Mar 1 2024 |
FDA Proposes Rule to Update Clinical Trial Data Monitoring |
McDermott Will & Schulte LLP |
